Phase IIIb trial evaluating
Xem 1-1 trên 1 kết quả Phase IIIb trial evaluating
-
PRECONNECT was an international, phase IIIb trial evaluating the safety and efficacy of trifluridine/tipiracil (FTD/TPI) for metastatic colorectal cancer (mCRC). Patients with mCRC received FTD/TPI 35mg/m2 twice-daily on days 1–5 and 8–12 of each 28-day cycle for third- or later-line treatment.
11p vischultz 20-10-2023 7 1 Download
CHỦ ĐỀ BẠN MUỐN TÌM
TOP DOWNLOAD